Literature DB >> 33582941

Classification of orthostatic intolerance through data analytics.

Steven Gilmore1, Joseph Hart2, Justen Geddes1, Christian H Olsen3, Jesper Mehlsen4, Pierre Gremaud1, Mette S Olufsen5.   

Abstract

Imbalance in the autonomic nervous system can lead to orthostatic intolerance manifested by dizziness, lightheadedness, and a sudden loss of consciousness (syncope); these are common conditions, but they are challenging to diagnose correctly. Uncertainties about the triggering mechanisms and the underlying pathophysiology have led to variations in their classification. This study uses machine learning to categorize patients with orthostatic intolerance. We use random forest classification trees to identify a small number of markers in blood pressure, and heart rate time-series data measured during head-up tilt to (a) distinguish patients with a single pathology and (b) examine data from patients with a mixed pathophysiology. Next, we use Kmeans to cluster the markers representing the time-series data. We apply the proposed method analyzing clinical data from 186 subjects identified as control or suffering from one of four conditions: postural orthostatic tachycardia (POTS), cardioinhibition, vasodepression, and mixed cardioinhibition and vasodepression. Classification results confirm the use of supervised machine learning. We were able to categorize more than 95% of patients with a single condition and were able to subgroup all patients with mixed cardioinhibitory and vasodepressor syncope. Clustering results confirm the disease groups and identify two distinct subgroups within the control and mixed groups. The proposed study demonstrates how to use machine learning to discover structure in blood pressure and heart rate time-series data. The methodology is used in classification of patients with orthostatic intolerance. Diagnosing orthostatic intolerance is challenging, and full characterization of the pathophysiological mechanisms remains a topic of ongoing research. This study provides a step toward leveraging machine learning to assist clinicians and researchers in addressing these challenges. Graphical abstract Machine learning tools utilized to analyze heart rate (HR) and blood pressure (BP) time-series data from syncope and control patients. Results show that machine learning can provide accurate classification of disease groups for 98% of patients and we identified two subgroups within the control patients differentiated by their BP response.

Entities:  

Keywords:  Classification; Clustering; Machine learning; Orthostatic intolerance; Syncope

Year:  2021        PMID: 33582941     DOI: 10.1007/s11517-021-02314-0

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  23 in total

1.  Effects of unilateral and bilateral carotid baroreflex stimulation on cardiac and neural sympathetic discharge oscillatory patterns.

Authors:  Raffaello Furlan; André Diedrich; Alexandra Rimoldi; Laura Palazzolo; Cesare Porta; Laura Diedrich; Paul A Harris; Peter Sleight; Italo Biagioni; David Robertson; Luciano Bernardi
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

Review 2.  Diagnosis and treatment of syncope.

Authors:  Michele Brignole
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

3.  Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control.

Authors:  R Furlan; G Jacob; M Snell; D Robertson; A Porta; P Harris; R Mosqueda-Garcia
Journal:  Circulation       Date:  1998-11-17       Impact factor: 29.690

4.  Characterization of Blood Pressure and Heart Rate Oscillations of POTS Patients via Uniform Phase Empirical Mode Decomposition.

Authors:  Justen Geddes; Jesper Mehlsen; Mette S Olufsen
Journal:  IEEE Trans Biomed Eng       Date:  2020-02-14       Impact factor: 4.538

5.  2018 ESC Guidelines for the diagnosis and management of syncope.

Authors:  Michele Brignole; Angel Moya; Frederik J de Lange; Jean-Claude Deharo; Perry M Elliott; Alessandra Fanciulli; Artur Fedorowski; Raffaello Furlan; Rose Anne Kenny; Alfonso Martín; Vincent Probst; Matthew J Reed; Ciara P Rice; Richard Sutton; Andrea Ungar; J Gert van Dijk
Journal:  Eur Heart J       Date:  2018-06-01       Impact factor: 29.983

6.  Cardiac origins of the postural orthostatic tachycardia syndrome.

Authors:  Qi Fu; Tiffany B Vangundy; M Melyn Galbreath; Shigeki Shibata; Manish Jain; Jeffrey L Hastings; Paul S Bhella; Benjamin D Levine
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

7.  'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope.

Authors:  A Bartoletti; P Alboni; F Ammirati; M Brignole; A Del Rosso; G Foglia Manzillo; C Menozzi; A Raviele; R Sutton
Journal:  Europace       Date:  2000-10       Impact factor: 5.214

8.  The prevalence and prognostic significance of near syncope and syncope: a prospective study of 395 cases in an emergency department (the SPEED study).

Authors:  Yvonne Greve; Felicitas Geier; Steffen Popp; Thomas Bertsch; Katrin Singler; Florian Meier; Alexander Smolarsky; Harald Mang; Christian Müller; Michael Christ
Journal:  Dtsch Arztebl Int       Date:  2014-03-21       Impact factor: 5.594

9.  Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals.

Authors:  Michele Brignole; Andrea Ungar; Ivo Casagranda; Michele Gulizia; Maurizio Lunati; Fabrizio Ammirati; Attilio Del Rosso; Massimo Sasdelli; Massimo Santini; Roberto Maggi; Elena Vitale; Alessandro Morrione; Giuseppina Maura Francese; Maria Rita Vecchi; Franco Giada
Journal:  Europace       Date:  2010-01       Impact factor: 5.214

10.  The impact of gender on the frequency of syncope provoking factors and prodromal signs in patients with vasovagal syncope.

Authors:  Katarzyna Cubera; Piotr J Stryjewski; Agnieszka Kuczaj; Jadwiga Nessler; Ewa Nowalany-Kozielska; Jolanta Pytko-Polończyk
Journal:  Przegl Lek       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.